Cargando…
Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis
BACKGROUND: Metastatic malignant melanoma is one of the most aggressive malignancies and its treatment remains challenging. Recent studies demonstrate that the melanoma metastasis has correlations with the heightened activations of protein kinase C ζ (PKCζ) and cyclooxygenase-2 (COX-2) signaling pat...
Autores principales: | Zhou, Ping, Qin, Jiaqi, Li, Yuan, Li, Guoxia, Wang, Yinsong, Zhang, Ning, Chen, Peng, Li, Chunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581453/ https://www.ncbi.nlm.nih.gov/pubmed/28865485 http://dx.doi.org/10.1186/s13046-017-0585-2 |
Ejemplares similares
-
Correction to: Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis
por: Zhou, Ping, et al.
Publicado: (2021) -
Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors
por: Ratnayake, Wishrawana S., et al.
Publicado: (2018) -
O-GlcNAc on PKCζ Inhibits the FGF4-PKCζ-MEK-ERK1/2 Pathway via Inhibition of PKCζ Phosphorylation in Mouse Embryonic Stem Cells
por: Miura, Taichi, et al.
Publicado: (2017) -
Association of PKCζ Expression with Clinicopathological Characteristics of Breast Cancer
por: Yin, Jian, et al.
Publicado: (2014) -
FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma
por: Tarin, Malcy, et al.
Publicado: (2023)